Premenopausal breast cancer: Estrogen receptor status and insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), and leptin

Breast Journal

Volumn 15, Issue 4, 2009, Pages 426-428

  Eng Wong, Jennifer ^a,b   Perkins, Susan N ^c   Bondy, Melissa ^d   Li, Donghui ^d   Eva Singletary, Sonya ^d   Núñez, Nomelí ^c   Hursting, Stephen ^c   Chang, Shine ^d  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; BODY MASS; BODY SIZE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DENMARK; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE DETERMINATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; QUESTIONNAIRE; RISK ASSESSMENT; UNIVARIATE ANALYSIS;

BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; NEOPLASM INVASIVENESS; PREMENOPAUSE; QUESTIONNAIRES; RECEPTORS, ESTROGEN;

EID: 67650739290     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00753.x     Document Type: Letter

References (7)

1. Renehan AG, Egger M, Minder C, et al. IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 2005 115 : 1006 7.
2. Fletcher O, Gibson L, Johnson N, et al. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: A systematic review. Cancer Epidemiol Biomarkers Prev 2005 14 : 2 19. (Pubitemid 40165277)
3. Mantzoros CS, Bolhke K, Moschos S, Cramer DW. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 1999 80 : 523 6.
4. Gronbaek H, Tanos V, Meirow D, et al. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients. Anticancer Res 2003 23 : 2815 20.
5. Goodwin PJ, Ennis M, Pritchard KI, et al. Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res Treat 2002 74 : 65 76. (Pubitemid 34734598)
6. Goodwin PJ, Ennis M, Fantus IG, et al. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 2005 23 : 6037 42.
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003 348 : 1625 38.